Progenics Pharmaceuticals, Inc. (PGNX)
-NasdaqGS 4.34 
0.37(9.32%) 4:00PM EDT|After Hours
:
4.34 0.00 (0.00%) 4:26PM EDT - Nasdaq Real Time Price
| Prev Close: | 3.97 |
|---|
| Open: | 4.12 |
|---|
| Bid: | 4.33 x 3300 |
|---|
| Ask: | 4.34 x 18700 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | 1.55 |
|---|
| Next Earnings Date: | 6-May-13 |
|---|
| Day's Range: | 3.99 - 4.51 |
|---|
| 52wk Range: | 1.41 - 11.00 |
|---|
| Volume: | 274,918 |
|---|
| Avg Vol (3m): | 434,775 |
|---|
| Market Cap: | 201.97M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -1.02 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Short Interest Moves 19% Higher For PGNXat TheStreet(Thu, Apr 25)
- Progenics Pharmaceuticals to Present at Needham Healthcare ConferenceGlobeNewswire(Wed, Apr 24)
- Why Progenics Is Poised to Pull Backat Motley Fool(Wed, Apr 24)
- PROGENICS PHARMACEUTICALS INC Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Financial StaEDGAR Online(Thu, Apr 4)
- Cramer: Buy Safeway, Priceline, and These 3 Stocks Nowat Wall St. Cheat Sheet(Tue, Apr 2)
- 'Mad Money' Lightning Round: I Like Pricelineat TheStreet(Tue, Apr 2)
- Cramer's Lightning Round - Priceline Is Not A Pricey Stock (4/1/13)at Seeking Alpha(Tue, Apr 2)
- Lightning Round: Priceline, EBay & Moreat CNBC(Mon, Apr 1)
- [video] Lightning Roundat CNBC(Mon, Apr 1)
- PROGENICS PHARMACEUTICALS INC FinancialsEDGAR Online Financials(Thu, Mar 21)
- Strong Relistor Sales Drive New Rally In Progenicsat Seeking Alpha(Tue, Mar 19)
- New Star Analyst Rankings for Progenics Pharmaceuticals Inc.StarMine(Mon, Mar 18)
- Investors are Digesting These Financial Stock Earnings Insightsat Wall St. Cheat Sheet(Sat, Mar 16)
- PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online(Fri, Mar 15)
- Furious Two-Way Intel Options Action, Rite-Aid Draws In Bullsat Forbes(Fri, Mar 15)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 13.15 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.79 |
|---|
| Quarterly EPS Est
(Mar-13)
: | -0.19 |
|---|
| Mean Recommendation*: | 3.0 |
|---|
| PEG Ratio (5 yr expected): | -0.25 |
|---|
Business Summary
Progenics Pharmaceuticals, Inc. engages in the research and development of biotechnology product candidates in the areas of oncology and therapeutics worldwide.
View More